Hybrid Scaffolds Decouple Biochemical & Biophysical Regulation of Cell Phenotype
The extracellular matrix changes dramatically during the progression of diseases like cancer. These complex, tissue-specific changes are not adequately replicated by most current biomaterial disease models. Here we demonstrate, for the first time, a biomaterial system allowing combined, independent control over stiffness, composition and 3D collagen architecture. We demonstrate successful perfusion of defined hydrogel formulations into ice-templated collagen scaffolds, controlling the composition of these hybrid scaffolds at constant stiffness. The Youngs moduli of these hybrid scaffolds can also be tuned independently of composition via chemical crosslinking. Encapsulation of human dermal fibroblasts reveals that fibroblast morphology depends on hybrid scaffold composition and on viscoelasticity, highlighting the importance of a system that decouples biophysical from biochemical properties. Finally, we demonstrate application of this system to exert combined control over biochemical and biophysical drivers of cell growth and invasion, focussing on breast cancer as proof-of-concept. We show that collagen fibre patterning enhances breast cancer cell proliferation, also directing the invasion of patient-derived breast cancer cells. These hybrid scaffolds are therefore promising new tools for dissecting the diverse but complementary roles played by the extracellular matrix in regulating cell phenotype, in a range of healthcare applications.